中文
| Catalogue |
|
|
| Recommend Products |
Exothera SA
Belgium, Manufacturer, Hits: 462, Updated:2/2/2023
Zoning de Jumet, Allée Centrale 52, 6040 Jumet - BELGIUM |
Company Profile
-
Exothera is a viral vector CDMO using standard and innovative bioproduction platforms to rapidly deliver affordable viral vector-based vaccines and cell and gene therapies. As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide custom-made process optimization and GMP clinical and commercial production of viral vectors. Based on its extensive technology expertise, Exothera selects technologies to optimally answer customer needs for cost-effective and agile viral vector manufacturing and provides QC services and analytical development.
Company News
- Exothera Announced the Appointment of Cedric Volanti as CEO 10/9/2024
- Exothera’s CTO Patrick Thiaville Nominated as a Member of Alliance for mRNA Medicines Board 12/1/2023
- NIH and Exothera Collaborate to Produce GMP Intranasal Vaccine Against SARS-CoV-2 8/21/2023
- Exothera Nucleic Acids Strengthens Team with Industry Expert 5/9/2023
- Exothera Announces a Strategic Partnership with Quantoom Biosciences 4/27/2023
- Exothera Announces the Appointment of Darren Leva as Chief Business Officer 2/2/2023